These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 26978355)
1. Molecular Selection, Modification and Development of Therapeutic Oligonucleotide Aptamers. Yu Y; Liang C; Lv Q; Li D; Xu X; Liu B; Lu A; Zhang G Int J Mol Sci; 2016 Mar; 17(3):358. PubMed ID: 26978355 [TBL] [Abstract][Full Text] [Related]
2. Aptamers as Therapeutic Agents: Has the Initial Euphoria Subsided? Haßel SK; Mayer G Mol Diagn Ther; 2019 Jun; 23(3):301-309. PubMed ID: 31037641 [TBL] [Abstract][Full Text] [Related]
3. Aptamers: from bench side research towards patented molecules with therapeutic applications. Majumder P; Gomes KN; Ulrich H Expert Opin Ther Pat; 2009 Nov; 19(11):1603-13. PubMed ID: 19852719 [TBL] [Abstract][Full Text] [Related]
4. Nucleic acid-based aptamers: applications, development and clinical trials. Kanwar JR; Roy K; Maremanda NG; Subramanian K; Veedu RN; Bawa R; Kanwar RK Curr Med Chem; 2015; 22(21):2539-57. PubMed ID: 25723512 [TBL] [Abstract][Full Text] [Related]
5. Aptamers in hematological malignancies and their potential therapeutic implications. Ouyang W; Yu Z; Zhao X; Lu S; Wang Z Crit Rev Oncol Hematol; 2016 Oct; 106():108-17. PubMed ID: 27637356 [TBL] [Abstract][Full Text] [Related]
6. Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes. Ni S; Yao H; Wang L; Lu J; Jiang F; Lu A; Zhang G Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28767098 [TBL] [Abstract][Full Text] [Related]
10. RNA aptamers: a review of recent trends and applications. Kang KN; Lee YS Adv Biochem Eng Biotechnol; 2013; 131():153-69. PubMed ID: 22491855 [TBL] [Abstract][Full Text] [Related]
11. Advances in aptamers. Syed MA; Pervaiz S Oligonucleotides; 2010 Oct; 20(5):215-24. PubMed ID: 20677985 [TBL] [Abstract][Full Text] [Related]
12. Recent Progress in Aptamer Discoveries and Modifications for Therapeutic Applications. Ni S; Zhuo Z; Pan Y; Yu Y; Li F; Liu J; Wang L; Wu X; Li D; Wan Y; Zhang L; Yang Z; Zhang BT; Lu A; Zhang G ACS Appl Mater Interfaces; 2021 Mar; 13(8):9500-9519. PubMed ID: 32603135 [TBL] [Abstract][Full Text] [Related]
13. The future of aptamers in medicine. Khati M J Clin Pathol; 2010 Jun; 63(6):480-7. PubMed ID: 20360137 [TBL] [Abstract][Full Text] [Related]
14. Predicting the Uncertain Future of Aptamer-Based Diagnostics and Therapeutics. Bruno JG Molecules; 2015 Apr; 20(4):6866-87. PubMed ID: 25913927 [TBL] [Abstract][Full Text] [Related]
15. Development of aptamer oligonucleotides as anticoagulants and antithrombotics for cardiovascular diseases: current status. Li W; Wang K; Zhao M; Yang X; Chen M; Lan X Thromb Res; 2014 Oct; 134(4):769-73. PubMed ID: 25113995 [TBL] [Abstract][Full Text] [Related]
16. Aptamers as promising molecular recognition elements for diagnostics and therapeutics in the central nervous system. McConnell EM; Holahan MR; DeRosa MC Nucleic Acid Ther; 2014 Dec; 24(6):388-404. PubMed ID: 25296265 [TBL] [Abstract][Full Text] [Related]
17. The development and testing of aptamers for cancer. Barbas AS; White RR Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946 [TBL] [Abstract][Full Text] [Related]
18. Nucleic acid aptamers: clinical applications and promising new horizons. Ni X; Castanares M; Mukherjee A; Lupold SE Curr Med Chem; 2011; 18(27):4206-14. PubMed ID: 21838685 [TBL] [Abstract][Full Text] [Related]